These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 22176433)
1. Bone morphogenetic protein-induced inflammatory cyst formation after lumbar fusion causing nerve root compression. Choudhry OJ; Christiano LD; Singh R; Golden BM; Liu JK J Neurosurg Spine; 2012 Mar; 16(3):296-301. PubMed ID: 22176433 [TBL] [Abstract][Full Text] [Related]
2. Revision surgery after interbody fusion with rhBMP-2: a cautionary tale for spine surgeons. Rodgers SD; Marascalchi BJ; Grobelny BT; Smith ML; Samadani U J Neurosurg Spine; 2013 Jun; 18(6):582-7. PubMed ID: 23560709 [TBL] [Abstract][Full Text] [Related]
3. Recombinant human bone morphogenetic protein-2-induced radiculitis in elective minimally invasive transforaminal lumbar interbody fusions: a series review. Mindea SA; Shih P; Song JK Spine (Phila Pa 1976); 2009 Jun; 34(14):1480-4; discussion 1485. PubMed ID: 19525840 [TBL] [Abstract][Full Text] [Related]
4. Symptomatic calcified perineural cyst after use of bone morphogenetic protein in transforaminal lumbar interbody fusion: a case report. Than KD; Rahman SU; McKeever PE; Wang AC; La Marca F; Park P Spine J; 2013 Aug; 13(8):e31-5. PubMed ID: 23792101 [TBL] [Abstract][Full Text] [Related]
5. Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion. Chen NF; Smith ZA; Stiner E; Armin S; Sheikh H; Khoo LT J Neurosurg Spine; 2010 Jan; 12(1):40-6. PubMed ID: 20043763 [TBL] [Abstract][Full Text] [Related]
6. Clinical sequelae after rhBMP-2 use in a minimally invasive transforaminal lumbar interbody fusion. Singh K; Nandyala SV; Marquez-Lara A; Cha TD; Khan SN; Fineberg SJ; Pelton MA Spine J; 2013 Sep; 13(9):1118-25. PubMed ID: 24029138 [TBL] [Abstract][Full Text] [Related]
7. Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of five cases. Lewandrowski KU; Nanson C; Calderon R Spine J; 2007; 7(5):609-14. PubMed ID: 17526434 [TBL] [Abstract][Full Text] [Related]
8. Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2--but what is the cost? Mannion RJ; Nowitzke AM; Wood MJ Spine J; 2011 Jun; 11(6):527-33. PubMed ID: 20739225 [TBL] [Abstract][Full Text] [Related]
9. Acute epidural lipedema: a novel entity and potential complication of bone morphogenetic protein use in lumbar spine fusion. Merrick MT; Hamilton KD; Russo SS Spine J; 2013 Oct; 13(10):e15-9. PubMed ID: 23800822 [TBL] [Abstract][Full Text] [Related]
10. Vertebral osteolysis originating from subchondral cyst end plate defects in transforaminal lumbar interbody fusion using rhBMP-2. Report of two cases. Balseiro S; Nottmeier EW Spine J; 2010 Jul; 10(7):e6-e10. PubMed ID: 20488766 [TBL] [Abstract][Full Text] [Related]
11. Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2. Villavicencio AT; Burneikiene S; Nelson EL; Bulsara KR; Favors M; Thramann J J Neurosurg Spine; 2005 Dec; 3(6):436-43. PubMed ID: 16381205 [TBL] [Abstract][Full Text] [Related]
12. Neuroforaminal chondrocyte metaplasia and clustering associated with recombinant bone morphogenetic protein-2 usage in transforaminal lumbar interbody fusion. Christensen TJ; Annis P; Hohl JB; Patel AA Spine J; 2014 Jun; 14(6):e23-8. PubMed ID: 24291359 [TBL] [Abstract][Full Text] [Related]
13. Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Wong DA; Kumar A; Jatana S; Ghiselli G; Wong K Spine J; 2008; 8(6):1011-8. PubMed ID: 18037352 [TBL] [Abstract][Full Text] [Related]
14. Posterior decompression surgery for extraforaminal entrapment of the fifth lumbar spinal nerve at the lumbosacral junction. Matsumoto M; Watanabe K; Ishii K; Tsuji T; Takaishi H; Nakamura M; Toyama Y; Chiba K J Neurosurg Spine; 2010 Jan; 12(1):72-81. PubMed ID: 20043768 [TBL] [Abstract][Full Text] [Related]
15. Iatrogenic neurologic deficit after lumbar spine surgery: A review. Ghobrial GM; Williams KA; Arnold P; Fehlings M; Harrop JS Clin Neurol Neurosurg; 2015 Dec; 139():76-80. PubMed ID: 26386902 [TBL] [Abstract][Full Text] [Related]
17. Histopathologic inflammatory response induced by recombinant bone morphogenetic protein-2 causing radiculopathy after transforaminal lumbar interbody fusion. Muchow RD; Hsu WK; Anderson PA Spine J; 2010 Sep; 10(9):e1-6. PubMed ID: 20797648 [TBL] [Abstract][Full Text] [Related]
18. Postoperative Lumbar Fusion Bone Morphogenic Protein-Related Epidural Cyst Formation. Abel F; Tan ET; Sneag DB; Lebl DR; Chazen JL AJNR Am J Neuroradiol; 2023 Mar; 44(3):351-355. PubMed ID: 36797032 [TBL] [Abstract][Full Text] [Related]
19. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 2: BMP dosage-related complications and long-term outcomes in 509 patients. Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R Spine (Phila Pa 1976); 2013 Jun; 38(13):1137-45. PubMed ID: 23354111 [TBL] [Abstract][Full Text] [Related]
20. Complications associated with the use of the recombinant human bone morphogenetic proteins for posterior interbody fusions of the lumbar spine. Chrastil J; Low JB; Whang PG; Patel AA Spine (Phila Pa 1976); 2013 Jul; 38(16):E1020-7. PubMed ID: 23629484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]